Syringe use and reuse: Effects of syringe exchange programs in four cities

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue SUPPL., 1998, Pages

  Heimer, Robert ^a   Khoshnood, Kaveh ^a   Bigg, Dan ^b   Guydish, Joseph ^c   Junge, Benjamin ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chicago Recovery Alliance   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Drug users; Needle and syringe exchange; Prevention programs; Syringe sharing

Indexed keywords

ARTICLE; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK MANAGEMENT; SELF REPORT; SYRINGE; UNITED STATES; VIRUS HEPATITIS; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0032125136     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199802001-00008     Document Type: Article

References (31)

1. National Commission on AIDS. The twin epidemics of substance abuse and HIV. Washington DC: National Commission on AIDS, July 1991.
2. Auerbach JD, Wypijewska C, Brodle HKH. AIDS and behavior: an integrated approach. Washington, DC: Institute of Medicine, 1994.
3. Brettle RP. HIV and harm reduction for injection drug users. AIDS 1991;5:125-36.
4. Gostin L. The needle-borne HIV epidemic: causes and public health responses. Behav Sci Law 1991;9:287-304.
5. Watters JK, Jones TS, Shapshak P, et al. Household bleach as disinfectant for use by injecting drug users [letter]. Lancet 1993; 342:742-3.
6. Watters JK. Historical perspective on the use of bleach in HIV/ AIDS prevention. J Acquir Immune Defic Syndr 1994;743-6.
7. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad. San Francisco: University of California, 1993.
8. Normand J, Vlahov D, Moses LE. Preventing HIV transmission: the role of sterile needles and bleach. Washington, DC: National Academy Press, 1995.
9. Paone D, Des Jarlais DC, Clark J, et al. Update: syringe exchange programs - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:565-8.
10. Nadel MV. Needle exchange programs: research suggests promise as an AIDS preventions strategy. Publication GAO/HRD-93-60. Washington, DC: United States General Accounting Office, 1993.
11. Heimer R, Kaplan EH, Khoshnood K, et al. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. Am J Med 12993;95:214-20.
12. Kaplan EH, Heimer R. A circulation theory of needle exchange. AIDS 1994;8:567-74.
13. Watters JK, Estilo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994;271:115-20.
14. Stimson G, Donoghoe M. Alldritt L, Dolan K. HIV transmission risk behaviour of clients attending syringe-exchange schemes in England and Scotland. Br J Addict 1988;83:1449-55.
15. Hartgers C, Buning E, van Santen G, et al. The impact of the needle and syringe-exchange programmes in Amsterdam on injecting risk behaviour. AIDS 1989;3:571-6.
16. Hunter GM, Donoghoe MC, Stimson GV, et al. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993. AIDS 1995;9:493-501.
17. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic: injecting drug users in New York City, 1984 through 1992. JAMA 1994;271:121-7.
18. Kaplan EH. Evaluating needle exchange programs via syringe tracking and testing. AIDS Public Policy J 1991;6:109-15.
19. Guydish J, Clark G, Garcia D, Bucardo J. Evaluation of needle exchange users using street-based survey methods. J Drug Issues 1995;25:33-41.
20. Guydish J, Bucardo J, Clark G, Bernheim S. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior. Subst Use Misuse 1998 (in press).
21. Vlahov D, Junge B, Beilenson P, et al. Evaluation of Baltimore needle exchange program: preliminary results. Presented at the XI International Conference on AIDS, Vancouver, Canada, 1996.
22. Heimer R, Kaplan EH, O'Keefe E, et al. Three years of needle exchange in New Haven: what have we learned? AIDS Public Policy J 1994;9:59-74.
23. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV-infected needles returned to New Haven's needle exchange program: client shift or needle exchange? Am J Public Health 1994;84:1991-4.
24. Heimer R, Khoshnood K, Jariwala-Freeman B, et al. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. J Infect Dis 1996;1273: 997-1000.
25. Kaplan EH, Heimer R. HIV incidence among needle exchange participants: estimates from syringe tracking and testing. J Acquir Immune Defic Syndr 1994;7:182-9.
26. Kaplan EH. A method for evaluating needle exchange programmes. Star Med 1994;13:2179-87.
27. Gleghorn AA, Jones TS, Doherty MC, et al. Acquisition and use of needles and syringes by injecting drug users in Baltimore, MD. J Acquir Immune Defic Syndr 1995;10:97-104.
28. Chaisson RE, Bacchetti P, Osmond D, et al. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261:561-5.
29. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321:874-9.
30. Anthony JC, Vlahov D, Nelson KE, et al. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 1991;134:1175-89.
31. Guydish J, Clark G, Garcia D, et al. Evaluating needle exchange: do distributed needles come back? Am J Public Health 1991;81: 617-9.